Td Waterhouse Canada Inc. Eli Lilly & CO Transaction History

Td Waterhouse Canada Inc.

$13.3 Trillion
Q1 2024

A detailed history of Td Waterhouse Canada Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 72,067 shares of LLY stock, worth $55.5 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

72,067

Previous 75,774 4.89%

Holding current value

$55.5 Million

Previous $49.9 Billion 20.73%

% of portfolio

0.45%

Previous 0.47%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$592.2 - $792.28 $2.2 Million - $2.94 Million	-3,707 Reduced 4.89%	72,067 $60.3 Billion
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $5.48 Million - $6.46 Million	10,437 Added 15.97%	75,774 $49.9 Billion
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $3.07 Million - $4.23 Million	7,057 Added 12.11%	65,337 $39 Billion
Q2 2023 Nov 13, 2023	SELL	$350.74 - $468.98 $4.61 Million - $6.16 Million	-13,138 Reduced 18.4%	58,280 $29.7 Billion
Q1 2023 Nov 13, 2023	SELL	$310.63 - $364.82 $2.17 Million - $2.54 Million	-6,973 Reduced 8.9%	71,418 $28.9 Billion

Q4 2022 Nov 13, 2023	BUY	$321.55 - $374.67 $4.67 Million - $5.45 Million	14,538 Added 22.77%	78,391 $33.5 Billion
Q3 2022 Nov 13, 2023	SELL	$296.48 - $337.87 $3.92 Million - $4.47 Million	-13,225 Reduced 17.16%	63,853 $22.9 Billion
Q2 2022 Nov 13, 2023	BUY	$278.73 - $327.27 $2.38 Million - $2.8 Million	8,541 Added 12.46%	77,078 $28 Billion
Q1 2022 Nov 13, 2023	SELL	$234.69 - $291.66 $6.76 Million - $8.4 Million	-28,809 Reduced 29.59%	68,537 $21.8 Billion
Q4 2021 Nov 13, 2023	BUY	$224.85 - $279.04 $21.9 Million - $27.2 Million	97,346 New	97,346 $27.8 Billion

Others Institutions Holding LLY

# of Institutions

3,703

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $732B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

News

Stay updated on Td Waterhouse Canada Inc. with notifications on news.

Account

Td Waterhouse Canada Inc. Eli Lilly & CO Transaction History